Venetoclax

Common brands: Venclexta, Vidaza, Onureg, Azacitidine, Azacitidine Azacitidine

Top reporter: Abbvie Inc.

BCL-2 Inhibitor [EPC]Nucleoside Metabolic Inhibitor [EPC]Xanthine Oxidase Inhibitor [EPC]CD20-directed Cytolytic Antibody [EPC]Corticosteroid [EPC]
59,616
Total Reports
44,886
Serious Reports
16,938
Death Reports
30
Reported Reactions
Death Report Ratio: High (28.41%)

Patient Demographics

Male
33,154
Female
20,607

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Venetoclax.

# Reaction Reports % of Total
1 DEATH 9,996
14.6%
2 OFF LABEL USE 6,655
9.7%
3 NEUTROPENIA 3,339
4.9%
4 FEBRILE NEUTROPENIA 3,033
4.4%
5 PLATELET COUNT DECREASED 2,723
4.0%
6 PYREXIA 2,658
3.9%
7 PNEUMONIA 2,605
3.8%
8 FATIGUE 2,546
3.7%
9 MYELOSUPPRESSION 2,438
3.6%
10 DIARRHOEA 2,308
3.4%
11 WHITE BLOOD CELL COUNT DECREASED 2,194
3.2%
12 NAUSEA 2,060
3.0%
13 THROMBOCYTOPENIA 2,043
3.0%
14 INFECTION 1,926
2.8%
15 ANAEMIA 1,881
2.7%
16 ACUTE MYELOID LEUKAEMIA 1,803
2.6%
17 ASTHENIA 1,728
2.5%
18 COVID-19 1,640
2.4%
19 HAEMOGLOBIN DECREASED 1,566
2.3%
20 DRUG INEFFECTIVE 1,534
2.2%
21 DISEASE PROGRESSION 1,433
2.1%
22 HOSPITALISATION 1,305
1.9%
23 SEPSIS 1,303
1.9%
24 PANCYTOPENIA 1,229
1.8%
25 ATRIAL FIBRILLATION 1,154
1.7%
26 TUMOUR LYSIS SYNDROME 1,120
1.6%
27 CYTOPENIA 1,108
1.6%
28 NEUTROPHIL COUNT DECREASED 1,085
1.6%
29 HOSPICE CARE 1,051
1.5%
30 DYSPNOEA 1,046
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.